Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
EDQM
0
USP
0
JP
0
Others
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
1. (2s)-3-(3-((4-chlorophenyl)methyl)-2,6-dioxo-4-(4-pyridin-2-yloxyanilino)-1,3,5-triazin-1-yl)-2-methylpropanoic Acid
1. 2414285-40-6
2. Sivopixant [inn]
3. S0n1veg94i
4. S-600918
5. Unii-s0n1veg94i
6. (2s)-3-[3-[(4-chlorophenyl)methyl]-2,6-dioxo-4-(4-pyridin-2-yloxyanilino)-1,3,5-triazin-1-yl]-2-methylpropanoic Acid
7. Compound 28 [pmid: 34587541]
8. 1,3,5-triazine-1(2h)-propanoic Acid, 3-((4-chlorophenyl)methyl)tetrahydro-alpha-methyl-2,6-dioxo-4-((4-(2-pyridinyloxy)phenyl)imino)-, (alphas,4e)-
9. Compound 28 (pmid: 34587541)
10. 1,3,5-triazine-1(2h)-propanoic Acid, 3-((4-chlorophenyl)methyl)tetrahydro-.alpha.-methyl-2,6-dioxo-4-((4-(2-pyridinyloxy)phenyl)imino)-, (.alpha.s,4e)-
11. (2s)-3-(3-((4-chlorophenyl)methyl)-2,6-dioxo-4-(4-pyridin-2-yloxyanilino)-1,3,5-triazin-1-yl)-2-methylpropanoic Acid
12. (e/z)-sivopixant
13. 1640808-39-4
14. Sivopixant?
15. Sivopixant (jan/inn)
16. Chembl5084939
17. Schembl16309814
18. Schembl23716843
19. Gtpl11756
20. Bdbm271626
21. Ex-a5402
22. Akos040757726
23. Akos040759920
24. Hy-137451a
25. Us10065941, Compound I-127
26. Ac-37122
27. Da-57909
28. Ms-29437
29. Hy-137451
30. Cs-0138657
31. Cs-0146664
32. D12355
33. G17804
34. (s,e)-3-(3-(4-chlorobenzyl)-2,6-dioxo-4-((4-(pyridin-2-yloxy)phenyl)imino)-1,3,5-triazinan-1-yl)-2-methylpropanoic Acid
| Molecular Weight | 507.9 g/mol |
|---|---|
| Molecular Formula | C25H22ClN5O5 |
| XLogP3 | 3.8 |
| Hydrogen Bond Donor Count | 2 |
| Hydrogen Bond Acceptor Count | 6 |
| Rotatable Bond Count | 9 |
| Exact Mass | Da |
| Monoisotopic Mass | Da |
| Topological Polar Surface Area | 124 |
| Heavy Atom Count | 36 |
| Formal Charge | 0 |
| Complexity | 826 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 1 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
Treatment of unexplained or refractory chronic cough
ABOUT THIS PAGE
24
PharmaCompass offers a list of Sivopixant API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Sivopixant manufacturer or Sivopixant supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Sivopixant manufacturer or Sivopixant supplier.
PharmaCompass also assists you with knowing the Sivopixant API Price utilized in the formulation of products. Sivopixant API Price is not always fixed or binding as the Sivopixant Price is obtained through a variety of data sources. The Sivopixant Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Sivopixant manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Sivopixant, including repackagers and relabelers. The FDA regulates Sivopixant manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Sivopixant API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Sivopixant supplier is an individual or a company that provides Sivopixant active pharmaceutical ingredient (API) or Sivopixant finished formulations upon request. The Sivopixant suppliers may include Sivopixant API manufacturers, exporters, distributors and traders.
Sivopixant Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Sivopixant GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Sivopixant GMP manufacturer or Sivopixant GMP API supplier for your needs.
A Sivopixant CoA (Certificate of Analysis) is a formal document that attests to Sivopixant's compliance with Sivopixant specifications and serves as a tool for batch-level quality control.
Sivopixant CoA mostly includes findings from lab analyses of a specific batch. For each Sivopixant CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Sivopixant may be tested according to a variety of international standards, such as European Pharmacopoeia (Sivopixant EP), Sivopixant JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Sivopixant USP).
